Fate of diclofenac in municipal wastewater treatment plant - A review

Environment International

Volumn 69, Issue , 2014, Pages 28-39

  Vieno, Niina ^a   Sillanpää, Mika ^b  

^a Logomo Byrå   (Finland)

^b LAPPEENRANTA UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Attached growth bioreactor; Biotransformation; Conventional activated sludge; Membrane bioreactor; Pharmaceutical; Sorption

Indexed keywords

BIOCONVERSION; BIOREACTORS; DRUG PRODUCTS; METABOLISM; RECLAMATION; RESEARCH; SORPTION; WASTEWATER TREATMENT;

BIOLOGICAL NUTRIENT REMOVAL; BIOLOGICAL WASTE WATER TREATMENT; BIOTRANSFORMATION; CONVENTIONAL ACTIVATED SLUDGES; MEMBRANE BIO REACTOR (MBR); MEMBRANE BIOREACTOR; MUNICIPAL WASTEWATER TREATMENT PLANTS; WASTEWATER TREATMENT PROCESS;

EFFLUENTS;

DICLOFENAC; DRINKING WATER;

BIOREACTOR; CONCENTRATION (COMPOSITION); ENVIRONMENTAL FATE; ENVIRONMENTAL MONITORING; MEMBRANE; POLLUTANT REMOVAL; SLUDGE; SORPTION; WASTE TREATMENT; WASTEWATER;

ACTIVATED SLUDGE; ATTACHED GROWTH BIOREACTOR; BIODEGRADABILITY; BIOLOGICAL NUTRIENT REMOVAL; BIOREACTOR; BIOTRANSFORMATION; CONCENTRATION (PARAMETERS); DRUG METABOLISM; ECOTOXICOLOGY; EFFLUENT; ELIMINATION REACTION; HYDRAULIC RETENTION TIME; MEMBRANE REACTOR; MICROBIAL COMMUNITY; MICROBIAL DEGRADATION; PHYSICAL PARAMETERS; POLLUTION TRANSPORT; PRIORITY JOURNAL; REVIEW; SLUDGE TREATMENT; SOLID RETENTION TIME; WASTE COMPONENT REMOVAL; WASTE WATER TREATMENT PLANT;

ATTACHED-GROWTH BIOREACTOR; BIOTRANSFORMATION; CONVENTIONAL ACTIVATED SLUDGE; MEMBRANE BIOREACTOR; PHARMACEUTICAL; SORPTION;

ADSORPTION; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIODEGRADATION, ENVIRONMENTAL; BIOREACTORS; DICLOFENAC; HUMANS; MOLECULAR STRUCTURE; SEWAGE; TIME FACTORS; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84899763475     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2014.03.021     Document Type: Review

References (113)

1. Andreozzi R., Marotta R., Paxéus N. Pharmaceuticals in STP effluents and their solat photodegradation in aquatic environment. Chemosphere 2003, 50:1319-1330.
2. Barbiere M., Carrera J., Ayora C., Sanchez-Vila X., Licha T., Nödler K., et al. Formation of diclofenac and sulfamethoxazole reversible transformation products in aquifer material under denitrifying conditions: batch experiments. Sci Total Environ 2012, 426:256-263.
3. Bendz B., Paxéus N.A., Ginn T.R., Loge F.J. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. J Hazard Mater 2005, 122:195-204.
4. Benotti M.J., Trendholm R.A., Vanderford B.J., Holady J.C., Stanford B.D., Snyder S.A. Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ Sci Technol 2009, 43:597-603.
5. Bernhard M., Müller J., Knepper T.P. Biodegradation of persistent polar pollutants in wastewater: comparison of an optimised lab-scale membrane bioreactor and activated sludge treatment. Water Res 2006, 40:3419-3428.
6. Blum W., Faigle J.W., Pfaar U., Sallamann A. Characterization of a novel diclofenac metabolite in human urine by capillary gas chromatography-negative chemical ionization mass spectrometry. J Chromatogr B Biomed Appl 1996, 685:251-263.
7. Brozinski J.-M., Lahti M., Meierjohann A., Oikari A., Kronberg L. The anti-inflammatory drugs diclofenac, naproxen and ibuprofen are found in the bile of wild fish caught downstream of a wastewater treatment plant. Environ Sci Technol 2013, 47:342-348.
8. Buser H.-F., Poiger T., Müller M.D. Occurrence and fate of the pharmaceutical drug diclofenac in surface waters: rapid photodegradation in a lake. Environ Sci Technol 1998, 32:3449-3456.
9. Carballa M. Fate of pharmaceuticals and personal care products (PPCPs) in sewage treatment plants focusing on the anaerobic digestion of sludge 2005, (Doctoral Thesis), Departamento de Ingeniería Química, Universidade de Santiago de Compostela, Spain.
10. Carballa M., Omil F., Lema J.M. Removal of cosmetic ingredients and pharmaceuticals in sewage primary treatment. Water Res 2005, 39:4790-4796.
11. Carballa M., Omil F., Ternes T., Lema J.M. Fate of pharmaceutical and personal care products (PPCPs) during anaerobic digestion of sewage sludge. Water Res 2007, 41:2139-2150.
12. Carballa M., Fink G., Omil F., Lema J.M., Ternes T. Determination of the solid-water distribution coefficient (Kd) for pharmaceuticals, estrogens and musk fragrances in digested sludge. Water Res 2008, 42(1-2):287-295.
13. Clara M., Strenn B., Gans O., Martinez E., Kreuzinger N., Kroiss H. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res 2005, 39:4797-4807.
14. Clara M., Kreuzinger N., Strenn B., Gans O., Kroiss H. The solids retention time-a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. Water Res 2005, 39:97-106.
15. Davies N.M., Anderson K.E. Clinical pharmacokinetics of diclofenac therapeutic insights and pitfalls. Clin Pharmacokinet 1997, 33:184-213.
16. de Graaff M.S., Vieno N.M., Kuwaja-Roeleveld K., Zeeman G., Temmink H., Buisman C.J.N. Fate of hormones and pharmaceuticals during combined anaerobic treatment and nitrogen removal by partial nitritation-anammox in vacuum collected black water. Water Res 2011, 45:375-383.
17. De Wever H., Weiss S., Reemtsma T., Vereecken J., Müller J., Knepper T., et al. Comparison of sulfonated and other micropollutants removal in membrane bioreactor and conventional wastewater treatment. Water Res 2007, 41:935-945.
18. Duan Y.-P., Meng X.-Z., Wen Z.-H., Chen L. Acidic pharmaceuticals in domestic wastewater and receiving water from hyper-urbanization city of China (Shanghai): environmental release and ecological risk. Environ Sci Pollut Res 2013, 20:108-116.
19. Eades C., Waring C.P. The effects of diclofenac on the physiology of the green shore crab Carcinus maenas. Mar Environ Res 2010, 69:S46-S48.
20. Ericson H., Thorsén G., Kumblad L. Physiological effects of diclofenac, ibuprofen and propranolol on Baltic Sea blue mussels. Aquat Toxicol 2010, 99:223-231.
21. EU Directive 2013/39/EU of the European Parliament and of the Council Available in www format: URL:. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2013:226:0001:0017:EN:PDF.
22. Faigle J.W., Böttcher I., Godbillon J., Kriemler H.P., Schlumpf E., Schneider W., et al. A new metabolite of diclofenac sodium in human plasma. Xenobiotica 1988, 18:1191-1197.
23. Falås P., Baillon-Bhumez A., Andersen H.R., Ledin A., la Cour Jansen J. Suspended biofilm carrier and activated sludge removal of acidic pharmaceuticals. Water Res 2012, 46:1167-1175.
24. Feito R., Valcárcel Y., Catalá M. Biomarker assessment of toxicity with miniaturised bioassays: declofenac as a case study. Ecotoxicology 2012, 21:289-296.
25. Fernandez-Fontaina E., Omil F., Lema J.M., Carballa M. Influence of nitrifying conditions on the biodegradation and sorption of emerging micropollutants. Water Res 2012, 46:5434-5444.
26. Ferrari B., Paxéus N., Giudice R.L., Pollio A., Garric J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol Environ Saf 2003, 55:359-370.
27. Finnish Medicines Agency Finnish statistic on medicines years 2008-2011 (in Finnish) Available in www format: URL:. http://www.fimea.fi/laaketieto/kulutustiedot.
28. Gaulke L.S., Strand S.E., Kalhorn T.F., Stensel H.D. 17α-Ethinylestradiol transformation via abiotic nitration in the presence of ammonia oxidizing bacteria. Environ Sci Technol 2008, 42:7622-7627.
29. Gómez M.J., Martínez Bueno M.J., Lacorte S., Fernández-Alba A.R., Agüera A. Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. Chemosphere 2007, 66:993-1002.
30. Gracia-Lor E., Sancho J.V., Serrano R., Hernández F. Occurrence and removal of pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area of Valencia. Chemosphere 2012, 87:453-462.
31. Gros M., Petrovic M., Ginebreda A., Barceló D. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ Int 2010, 36:15-26.
32. Haap T., Triebskorn R., Köhler H.-R. Acute effects of diclofenac and DMSO to Daphnia magna: immobilisation and hsp70-induction. Chemosphere 2008, 73:353-359.
33. Hallare A.V., Köhler H.-R., Triebskorn R. Developmental toxicity and stress protein responsed in zebrafish enbryos after exposure to diclofenac and its solvent, DMSO. Chemosphere 2004, 56:659-666.
34. Heberer T. Tracking persistence pharmaceuticals residues from municipal sewage to drinking water. J Hydrol 2002, 266:175-189.
35. Hernando M.D., Heath E., Petrovic M., Barceló D. Trace-level determination of pharmaceutical residues by LC-MS/MS in natural and treated waters. A pilot-survey study. Anal Bioanal Chem 2006, 385:985-991.
36. Hilton M.J., Thomas K.V. Determination of selected human pharmaceutical compounds in effluent and surface water samples by high performance liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr A 2003, 1015:129-141.
37. Jones O.A.H., Voulvoulis N., Lester J.N. The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilising activated sludge treatment. Environ Pollut 2007, 145:738-744.
38. Joss A., Keller E., Alder A.C., Göbel A., McArdell C.S., Ternes T., et al. Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res 2005, 39:3139-3315.
39. Joss A., Zabczynski S., Göbel A., Hoffmann B., Löffler D., McArdell C.S., et al. Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. Water Res 2006, 40:1686-1696.
40. Kallio J.-M., Lahti M., Oikari A., Kronberg L. Metabolites of the aquatic pollutant diclofenac in fish bile. Environ Sci Technol 2010, 44:7213-7219.
41. Khan S.J., Ongerth J.E. Modelling of pharmaceutical residues in Australian sewage by quantifies of use and fugacity calculations. Chemosphere 2004, 54(3):355-367.
42. Kim S.D., Cho J., Kim I.S., Vanderford B.J., Snyder S.A. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Res 2007, 41:1013-1021.
43. Kimura K., Hara H., Watanabe Y. Removal of pharmaceutical compounds by submerged membrane bioreactors (MBRs). Desalination 2005, 178:135-140.
44. Kimura K., Hara H., Watanabe Y. Elimination of selected acidic pharmaceuticals from municipal wastewater by an activated sludge system and membrane bioreactors. Environ Sci Technol 2007, 41:3708-3714.
45. Kosjek T., Heath E., Krbavcic A. Determination of non-steroidal anti-inflammatory drug (NSAIDs) residues in water samples. Environ Int 2005, 31:679-685.
46. Kosjek T., Heath E., Pérez S., Petrovic M., Barceló D. Metabolism studies of diclofenac and clofibric acid in activated sludge bioreactors using liquid chromatography with quadrupole-time-of-flight mass spectrometry. J Hydrol 2009, 372:109-117.
47. Kosma C.I., Lambropoulou D.A., Albanis T.A. Investigation of PPCPs in wastewater treatment plants in Greece: occurrence, removal and environmental risk assessment. Sci Total Environ 2014, 466-467:421-438.
48. Kraigher B., Mandic-Mulec I. Nitrification activity and community structure of nitrite-oxidizing bacteria in the bioreactors operated with addition of pharmaceuticals. J Hazard Mater 2011, 188:78-84.
49. Kraigher B., Kosjek T., Heath E., Kompare B., Mandic-Mulec I. Influence of pharmaceutical residues on the structure of activated sludge bacterial communities in wastewater treatment bioreactors. Water Res 2008, 42:4578-4588.
50. Kuster M., López de Alda M.J., Hernando M.D., Petrovic M., Martín-Alonso J., Barceló D. Analysis and occurrence of pharmaceuticals, estrogens, progestogens and polar pesticides in sewage treatment plant effluents, river water and drinking water in the Llobregat river basin (Barcelona, Spain). J Hydrol 2008, 358:112-123.
51. Langford K., Thomas K. Input of selected pharmaceutical metabolites into the Norwegian aquatic environment. J Environ Monit 2011, 13:416-421.
52. Lee H.-J., Lee E., Yoon S.-H., Chang H.-R., Kim K., Kwon J.-H. Enzymatic and microbial transformation assays for the evaluation of the environmental fate of diclofenac and its metabolites. Chemosphere 2012, 87:969-974.
53. Li Y., Zhu G., Ng W.J., Tan S.K. A review on removing pharmaceutical contaminants from wastewater by constructed wetlands: design, performance and mechanism. Sci Total Environ 2014, 468-469:908-932.
54. Lin W.C., Chen H.-C., Ding W.-H. Determination of pharmaceutical residues in waters by solid-phase extraction and large-volume on-line derivatization with gas chromatography-mass spectrometry. J Chromatogr A 2005, 1065:279-285.
55. Loos R., Locoro G., Comero S., Contini S., Schwesig D., Werres F., et al. Pan-European survey on the occurrence of selected polar organic persistent pollutants in ground water. Water Res 2010, 44:4115-4126.
56. López-Serna R., Jurado A., Vázques-Sune E., Carrera J., Petrovic M., Barceló D. Occurrence of 95 pharmaceuticals and transformation products in urban groundwaters underlying the metropolis of Barcelona, Spain. Environ Pollut 2013, 174:305-315.
57. Maeng S.-K., Choi B.G., Lee K.T., Song K.G. Influences of solid retention time, nitrification and microbial activity on the attenuation of pharmaceuticals and estrogens in membrane bioreactors. Water Res 2013, 47:3151-3162.
58. Martín J., Camacho-Munoz D., Santos J.L., Aparicio I., Alonso E. Occurrence of pharmaceutical compounds in wastewater and sludge from wastewater treatment plants: removal and ecotoxicological impact of wastewater discharges and sludge disposal. J Hazard Mater 2012, 239-240:40-47.
59. Maurer M., Escher B.I., Richle P., Schaffner C., Alder A.C. Elimination of β-blockers in sewage treatment plants. Water Res 2007, 41:1614-1622.
60. Metcalfe C.D., Miao X.-S., Koenig B.G., Struger J. Distribution and acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada. Environ Toxicol Chem 2003, 22(12):2881-2889.
61. Nam S.-W., Jo B.-I, Yoon Y., Zoh K.-D. Occurrence and removal of selected micropollutants in a water treatment plant. Chemosphere 2014, 95:156-165.
62. Nassef M., Kim S.G., Seki M., Kang I.J., Hano T., Shimasaki Y., et al. In ovo nanoinjection of triclosan, diclofenac and carbamazepine affects embryonic development of medaka fish (Oryzias latipes). Chemosphere 2010, 79:966-973.
63. Nguyen L.N., Hai F.I., Kang J., Price W.E., Nghiem L.D. Removal of trace organic contaminants by a membrane bioreactor-granular activated carbon (MBR-GAC) system. Bioresour Technol 2012, 113:169-173.
64. Nguyen L.N., Hai F.I., Kang J., Nghiem L.D., Price W.E., Guo W., et al. Comparison between sequential and simultaneous application of activated carbon with membrane bioreactor for trace organic contaminant removal. Bioresour Technol 2013, 130:412-417.
65. Öllers S., Singer H.P., Fässler P., Müller S.R. Simultaneous quantification of neutral and acidic pharmaceuticals and pesticides at the low-ng/l level in surface and waste water. J Chromatogr A 2001, 911:225-234.
66. Onesios K.M., Yu J.T., Bouwer E.J. Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: a review. Biodegradation 2009, 20:441-466.
67. Paxéus N. Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, β-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment. Water Sci Technol 2004, 50:253-260.
68. Perez S., Barcelo D. First evidence for occurrence of hydroxylated human metabolites of diclofenac and aceclofenac in wastewater using QqLIT-MS and QqTOF-MS. Anal Chem 2008, 80:8135-8145.
69. Petrovic M., Gros M., Barcelo D. Multi-residue analysis of pharmaceuticals in wastewater by ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry. J Chromatogr A 2006, 1124:68-81.
70. Quinn B., Schmidt W., O'Rourke K., Hernan R. Effects of the pharmaceuticals gemfibrozil and diclofenac on biomarker expression in the zebra mussel (Dreissena polymorpha) and their comparison with standardized toxicity tests. Chemosphere 2011, 84:657-663.
71. Quintana J.B., Reemtsma T. Sensitive determination of acidic drugs and triclosan in surface and wastewater by ion-pair reverse-phase liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2004, 18:765-774.
72. Quintana J.B., Weiss S., Reemtsma T. Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. Water Res 2005, 39:2654-2664.
73. Rabiet M., Togola A., Brissaud F., Seidel J.-L., Budzinski H., Elbaz-Poulicher F. Consequences of treated water recycling as regards pharmaceuticals and drugs in surface and ground waters of a medium-sized Mediterranean catchment. Environ Sci Technol 2006, 40:5282-5288.
74. Radjenovic J., Petrovic M., Barcelo D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. Water Res 2009, 43:831-841.
75. Ratola N., Cincinelli A., Alves A., Katsoyiannis A. Occurrence of organic microcontaminants in the wastewater treatment process. A mini review. J Hazard Mater 2012, 239-240:1-18.
76. Reif R., Suárez S., Omil F., Lema J.M. Fate of pharmaceuticals and cosmetic ingredients during the operation of a MBR treating sewage. Desalination 2008, 221:511-517.
77. Rodríguez-Rodríguez C.E., Jelic A., Alcina Pereira M., Sousa D.Z., Petrovic M., Dadalena Alves M., et al. Bioaugmentation of sewage sludge with Trametes versicolor in solid-phase biopiles produces degradation of pharmaceuticals and affects microbial communities. Environ Sci Technol 2012, 46:12012-12020.
78. Roh H., Subramanya N., Zhao F., Yu C.-P., Sandt J., Kung-Hui C. Biodegradation potential of wastewater micropollutants by ammonia-oxidizing bacteria. Chemosphere 2009, 77(8):1084-1089.
79. Rosal R., Rodríques A., Perdigón-Melón J.A., Petre A., García-Calvo E., José Gómez M., et al. Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. Water Res 2010, 44:578-588.
80. Drug consumption in Norway 2007-2011 2012, Norwegian Institute of Public Health, Oslo, [Available in www format: URL: http://www.legemiddelforbruk.no/english/]. S. Sakshaug (Ed.).
81. Samaras V.G., Stasinakis A.S., Mamais D., Thomaidis N.S., Lekkas T.D. Fate of selected pharmaceuticals and synthetic endocrine disrupting compounds during wastewater treatment and sludge anaerobic digestion. J Hazard Mater 2013, 244-245:259-267.
82. Scheurell M., Franke S., Shah R.M., Hühnerfuss H. Occurrence of diclofenac and its metabolites in surface water and effluent samples from Karachi, Pakistan. Chemosphere 2009, 77:870-876.
83. Schmitt-Jansen M., Bartels P., Adler N., Altenburger R. Phytotoxicity assessment of diclofenac and its phototransformation products. Anal Bioanal Chem 2007, 387:1389-1396.
84. Schwaiger J., Ferling H., Mallow U., Wintermayr H., Negele R.D. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: histopatological alterations and bioaccumulation in rainbow trout. Aquat Toxicol 2004, 68:141-150.
85. Sim W.-J., Lee J.-W., Lee E.-S., Shin S.-K., Hwang S.-R., Oh J.-E. Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures. Chemosphere 2011, 82:179-186.
86. Soulet B., Tauxe A., Tarradellas J. Analysis of acidic drugs in Swiss wastewaters. Int J Environ Chem 2002, 82:659-667.
87. SRC Interactive PhysProp database demo Available in www format: URL:. http://www.syrres.com/what-we-do/databaseforms.aspx?id=386.
88. Stierlin H., Faigle J.W. Biotransformation of diclofenac sodium (Voltaren®) in animals and in man. II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile. Xenobiotica 1979, 9(10):611-621.
89. Suárez S., Lema J.M., Omil F. Removal of pharmaceutical and personal care products (PPCPs) under nitrifying and denitrifying conditions. Water Res 2010, 44:3214-3224.
90. Suárez S., Reif R., Lema J.M., Omil F. Mass balance of pharmaceutical and personal care products in a pilot-scale single-sludge system: influence of T, SRT and recirculation ratio. Chemosphere 2012, 89:164-171.
91. Sui Q., Huang J., Deng S., Chen W., Yu G. Seasonal variation in the occurrence and removal of pharmaceuticals and personal care products in different biological wastewater treatment processes. Environ Sci Technol 2011, 45:3341-3348.
92. Svanfelt J. Occurrence and photochemical fate of selected pharmaceutical active ingredients in the aquatic environment 2013, (PhD Thesis), Åbo Akademi University, Turku, Finland, [Available at: http://www.doria.fi/bitstream/handle/10024/87829/svanfelt_jesper.pdf?sequence=2].
93. Tauxe-Wuersch A., De Alencastro L.F., Grandjean D., Tarradellas J. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Res 2005, 39:1761-1772.
94. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 1998, 32(11):3245-3260.
95. Ternes T.A., Herrmann N., Bonerz M., Knacker T., Siegrist H., Joss A. A rapid method to measure the solid-water distribution coefficient (Kd) for pharmaceuticals and musk fragrances in sewage sludge. Water Res 2004, 38:4075-4084.
96. Ternes T.A., Joss A., Siegrist H. Scrutinizing pharmaceuticals and personal care products in wastewater treatment. Environ Sci Technol 2004, 392A-399A. [A-pages, October 15].
97. Ternes T.A., Bonerz M., Herrmann N., Löffler D., Keller E., Bagó Lacida B., et al. Determination of pharmaceuticals, iodinated contrast media and musk fragrances in sludge by LC/tandem MS and GC/MS. J Chromatogr A 2005, 1067:213-223.
98. Tran N.H., Urase T., Kusakabe O. The characteristics of enriched nitrifier culture in the degradation of selected pharmaceutically active compounds. J Hazard Mater 2009, 171:1051-1057.
99. Triebskorn R., Casper H., Heyd A., Eikemper R., Köhler H.-R., Schwaiger J. Toxic effects of non-steroidal anti-inflammatory drug diclofenac. Part II. Cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). Aquat Toxicol 2004, 68:151-166.
100. Triebskorn R., Casper H., Scheil V., Scwaiger J. Ultrastructural effects of pharmaceuticals (carbamazepine, clofibric acid, metoprolol, diclofenac) in rainbow trout (Oncorhynchus mykiss) and common carp (Cyprinus carpio). Anal Bioanal Chem 2007, 387:1405-1416.
101. Urase T., Kikuta T. Separate estimation of adsorption and degradation of pharmaceutical substances and estrogens in the activated sludge process. Water Res 2005, 39:1289-1300.
102. Urase T., Kagawa C., Kikuta T. Factors affecting removal of pharmaceutical substances and estrogens in membrane separation bioreactors. Desalination 2005, 178:107-113.
103. Verlicchi P., Al Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment-a review. Sci Total Environ 2012, 429:123-155.
104. Vieno N. Occurrence of pharmaceuticals in Finnish sewage treatment plants, surface waters, and their elimination in drinking water treatment processes 2007, (PhD Thesis), Tampere University of Technology, Finland, [publication no 666. Available in www format: URL: http://dspace.cc.tut.fi/dpub/bitstream/handle/123456789/20/vieno.pdf?sequence=1].
105. Vulliet E., Cren-Olivé C., Grenier-Loustalot M.-F. Occurrence of pharmaceuticals and hormones in drinking water treated from surface waters. Environ Chem Lett 2011, 9:103-114.
106. Wang S., Gunsch C.K. Effects of selected pharmaceutically active compounds (ketoprofen, naproxen, carbamazepine and gemfibrozil) on treatment performance in sequencing batch reactors mimicking wastewater treatment plants operations. Water Res 2011, 45(11):3398-3406.
107. Wiesenberg-Boettcher I., Pfeilschifter J., Schweizer A., Sallmann A., Wenk P. Pharmacological properties of five diclofenac metabolites indentified in human plasma. Inflamm Res Agents Actions 1991, 34:135-137.
108. Xue W., Wu C., Xiao K., Huang X., Zhou H., Tsuno H., et al. Elimination and fate of selected micro-organic pollutants in a full-scale anaerobic/anoxic/aerobic process combined with membrane bioreactor for municipal wastewater reclamation. Water Res 2010, 44:5999-6010.
109. Yan Q., Gao X., Chen Y.-P., Peng X.-Y., Zhang Y.-X., Gan X.-M., et al. Occurrence, fate and ecotoxicological assessment of pharmaceutically active compounds in wastewater and sludge from wastewater treatment plants in Chongqing, the Three Gorges Researvoir Area. Sci Total Environ 2014, 470-471:618-630.
110. Yu J.T., Bouwer E.J., Coelhan M. Occurrence and biodegradability studies of selected pharmaceuticals and personal care products in sewage effluent. Agric Water Manag 2006, 86:72-80.
111. Yu Y., Wu L., Chang A.C. Seasonal variation of endocrine disrupting compounds, pharmaceuticals and personal care products in wastewater treatment plants. Sci Total Environ 2013, 442:310-316.
112. Zorita S., Mårtensson L., Mathiasson L. Occurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden. Sci Total Environ 2009, 407:2760-2770.
113. Zupanc M., Kosjek T., Petkovsek M., Dular M., Kompare B., Sirok B., et al. Removal of pharmaceuticals from wastewater by biological processes, hydrodynamic cavitation and UV treatment. Ultrason Sonochem 2013, 20(4):1104-1112.